PRECIGEN
LIVE

Serial Number

87366798

Owner

PRECIGEN, INC.

Attorney

David R. Kelly

First Use Date

Jan 1, 2018

Filing Date

Mar 10, 2017

Add to watchlist:

No watchlists yet
View on USPTO

PRECIGEN Trademark

Serial Number: 87366798 • Registration: 7026015

PRECIGEN is a trademark filed by PRECIGEN, INC. on March 10, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

PRECIGEN, INC. (55 trademarks)

1872 PRATT STREET, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

INTREXON CORPORATION (92 trademarks)

1872 PRATT DRIVE, SUITE 1400
BLACKSBURG, VA 24060

Entity Type: 03

Trademark Details

Filing Date

March 10, 2017

Registration Date

April 11, 2023

First Use Anywhere

January 1, 2018

First Use in Commerce

January 1, 2018

Published for Opposition

August 27, 2019

Goods & Services

Chemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; biochemical preparations for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; chemical reagents for medical and veterinary purposes, namely, for gene and cell therapy for treating genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders

Chemicals, biochemicals and reagents for use in industry and science; chemicals, biochemicals and reagents, namely, proteins for regulating, modifying or restricting gene expression; kits consisting primarily of proteins for regulating, modifying or restricting gene expression

Technology transfer services, namely, licensing of intellectual property

Medical services; Medical services, namely, genetic engineering, biopharmaceuticals and gene therapy services; Healthcare services, namely, treatment of patients with genetic disorders, cancers, rare diseases, infectious diseases, and cardiovascular and immunological diseases and disorders; Medical services, namely, providing medical therapy treatments which are under development or have completed development for patients in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular diseases

Scientific research and development services in the field of medicine, pharmacology, immunology, biochemistry, cell biology, genetics, microbiology and virology; Scientific research in the field of healthcare; Therapeutic research of treatments in the fields of oncology, rare diseases, metabolic disorders, infectious diseases, ophthalmology, and cardiovascular disease which are under development or have completed development; Development of products being genetic therapies, biopharmaceuticals, and effectors to regulate, modulate, and characterize disease states; Development of tools in the nature of software and biotechnological processes to regulate, modulate, and characterize disease states; Research and development services for others in the field of biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use; Research and development services for others in the fields of genetics and biotechnology, namely, genetically engineering DNA, biological organisms, cells, viruses, pathogens, and special purpose cells for scientific, research, medical and laboratory use

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Sep 24, 2025 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 7, 2024 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 7, 2024 ASCK
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 11, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 11, 2023 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 7, 2023 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 6, 2023 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 13, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Dec 13, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Oct 19, 2022 SUPC
USE AMENDMENT FILED
Oct 17, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 17, 2022 EISU
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 31, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 31, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 31, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 31, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 31, 2022 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2022 EXRA
SOU EXTENSION 5 GRANTED
Apr 11, 2022 EX5G
SOU EXTENSION 5 FILED
Apr 8, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Apr 8, 2022 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2021 EXRA
SOU EXTENSION 4 GRANTED
Oct 20, 2021 EX4G
SOU EXTENSION 4 FILED
Oct 20, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Oct 20, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2021 EXRA
SOU EXTENSION 3 GRANTED
Apr 20, 2021 EX3G
SOU EXTENSION 3 FILED
Apr 20, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 20, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 24, 2020 EXRA
SOU EXTENSION 2 GRANTED
Oct 22, 2020 EX2G
SOU EXTENSION 2 FILED
Oct 22, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 22, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 11, 2020 EXRA
SOU EXTENSION 1 GRANTED
Apr 10, 2020 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 10, 2020 AITU
SOU EXTENSION 1 FILED
Apr 8, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 8, 2020 EEXT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Apr 8, 2020 ASGN
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 22, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 27, 2019 NPUB
PUBLISHED FOR OPPOSITION
Aug 27, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 7, 2019 NONP
ASSIGNED TO LIE
Jul 19, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 10, 2019 CNSA
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 21, 2018 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 21, 2018 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 21, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 21, 2017 GNSL
SUSPENSION LETTER WRITTEN
Dec 21, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 5, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 5, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2017 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2017 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2017 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2017 NWOS
NEW APPLICATION ENTERED
Mar 14, 2017 NWAP